tert-Butyl 3-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]piperidine-1-carboxylate | 1178881-90-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 英文名称: tert-Butyl 3-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]piperidine-1-carboxylate
• 英文别名: tert-butyl 3-[(1,3-dioxoisoindol-2-yl)methyl]piperidine-1-carboxylate
• CAS: 1178881-90-7
• 化学式: C₁₉H₂₄N₂O₄
• 分子量: 344.411
• InChiKey: KNXRZDMBVOAOCQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  25
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  66.9
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  tert-Butyl 3-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]piperidine-1-carboxylate 在 一水合肼 作用下， 以 乙醇 为溶剂， 反应 24.0h， 以91%的产率得到1-Boc-3-氨甲基哌啶
  参考文献：
  名称：

  3-SUBSTITUTED SULFONYL PIPERAZINE DERIVATIVE

  摘要：

  公开号：

  EP2261210B1
• 作为产物：
  描述：

  邻苯二甲酸亚胺 、 1-Boc-3-羟甲基哌啶 在 偶氮二甲酸二异丙酯 、 三苯基膦 作用下， 以 四氢呋喃 为溶剂， 反应 24.0h， 以90%的产率得到tert-Butyl 3-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]piperidine-1-carboxylate
  参考文献：
  名称：

  3-SUBSTITUTED SULFONYL PIPERAZINE DERIVATIVE

  摘要：

  公开号：

  EP2261210B1

文献信息

• 3-substituted sulfonyl piperidine derivative
  申请人：MSD K.K.

  公开号：US08188280B2

  公开（公告）日：2012-05-29

  [Problem] There is provided a compound useful as a preventive or remedy for cardiovascular disease, neurologic disease, metabolic disease, reproductive disease, and digestive disease. [Means for Resolution] A compound or a pharmaceutically acceptable salt thereof represented by the following Formula (I) wherein Z represents wherein n1, n2, and n3 are 0, 1, or 2, respectively; R1 represents C1-6 alkyl, C3-8 cycloalkyl, or the like; R2 represents aryl or heteroaryl; R3 represents a hydrogen atom, C1-6 alkyl, or the like; and M1, M2, M3, and M4 independently represent a hydrogen atom, C1-6 alkyl, or the like, or M1, together with M2, M3, or M4, forms —CH2— or the like.

  【问题】提供了一种化合物，可用作心血管疾病、神经疾病、代谢性疾病、生殖疾病和消化疾病的预防或治疗药物。【解决方法】一种化合物或其药学上可接受的盐，其表示如下式（I）：其中Z表示：其中n1，n2和n3分别为0、1或2；R1表示C1-6烷基，C3-8环烷基或类似物；R2表示芳基或杂环芳基；R3表示氢原子，C1-6烷基或类似物；M1、M2、M3和M4分别独立地表示氢原子，C1-6烷基或类似物，或M1与M2、M3或M4一起形成—CH2—或类似物。
• 3-SUBSTITUTED SULFONYL PIPERIDINE DERIVATIVE
  申请人：Nagase Tsuyoshi

  公开号：US20120232109A1

  公开（公告）日：2012-09-13

  [Problem] There is provided a compound useful as a preventive or remedy for cardiovascular disease, neurologic disease, metabolic disease, reproductive disease, and digestive disease. [Means for Resolution] A compound or a pharmaceutically acceptable salt thereof represented by the following Formula (I) wherein Z represents wherein n1, n2, and n3 are 0, 1, or 2, respectively; R 1 represents C 1-6 alkyl, C 3-8 cycloalkyl, or the like; R 2 represents aryl or heteroaryl; R 3 represents a hydrogen atom, C 1-6 alkyl, or the like; and M 1 , M 2 , M 3 , and M 4 independently represent a hydrogen atom, C 1-6 alkyl, or the like, or M 1 , together with M 2 , M 3 , or M 4 , forms —CH 2 — or the like.

  [问题] 提供了一种化合物，可用作预防或治疗心血管疾病、神经疾病、代谢性疾病、生殖疾病和消化疾病的药物。[解决方法] 化合物或其药学上可接受的盐，由以下式（I）所表示的化合物其中Z表示其中n1、n2和n3分别为0、1或2；R1表示C1-6烷基、C3-8环烷基或类似物；R2表示芳基或杂环芳基；R3表示氢原子、C1-6烷基或类似物；M1、M2、M3和M4分别独立地表示氢原子、C1-6烷基或类似物，或M1与M2、M3或M4一起形成-CH2-或类似物。
• OGA INHIBITOR COMPOUNDS
  申请人：Janssen Pharmaceutica NV

  公开号：US20210300943A1

  公开（公告）日：2021-09-30

  The present invention relates to O-GlcNAc hydrolase (OGA) inhibitors. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention and treatment of disorders in which inhibition of OGA is beneficial, such as tauopathies, in particular Alzheimer's disease or progressive supranuclear palsy; and neurodegenerative diseases accompanied by a tau pathology, in particular amyotrophic lateral sclerosis or frontotemporal lobe dementia caused by C9ORF72 mutations.
• 3-SUBSTITUTED SULFONYL PIPERAZINE DERIVATIVE
  申请人：MSD K.K.

  公开号：EP2261210B1

  公开（公告）日：2014-10-22